CVE-2020-12037

Description

Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.

Categories

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.07%
Third-Party Advisory cisa.gov
Affected: n/a Baxter PrismaFlex and PrisMax
Published at:
Updated at:

References

Link Tags
https://www.us-cert.gov/ics/advisories/icsma-20-170-01 not applicable
https://us-cert.cisa.gov/ics/advisories/icsma-20-170-02 third party advisory

Frequently Asked Questions

What is the severity of CVE-2020-12037?
CVE-2020-12037 has been scored as a high severity vulnerability.
How to fix CVE-2020-12037?
To fix CVE-2020-12037, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-12037 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-12037 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-12037?
CVE-2020-12037 affects n/a Baxter PrismaFlex and PrisMax.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.